PBA
Paradigm Biocapital Advisors’s argenx ARGX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-59,679
| Closed | -$35.3M | – | 29 |
|
|
2025
Q1 | $35.3M | Sell |
59,679
-421,626
| -88% | -$250M | 1.62% | 15 |
|
|
2024
Q4 | $296M | Buy |
481,305
+931
| +0.2% | +$573K | 10.3% | 3 |
|
|
2024
Q3 | $260M | Sell |
480,374
-57,765
| -11% | -$31.3M | 8.81% | 3 |
|
|
2024
Q2 | $231M | Sell |
538,139
-13,981
| -3% | -$6.01M | 8.86% | 2 |
|
|
2024
Q1 | $217M | Buy |
552,120
+129,543
| +31% | +$51M | 7.65% | 3 |
|
|
2023
Q4 | $161M | Buy |
422,577
+161,134
| +62% | +$61.3M | 7.53% | 3 |
|
|
2023
Q3 | $129M | Buy |
261,443
+119,184
| +84% | +$58.6M | 8.72% | 2 |
|
|
2023
Q2 | $55.4M | Sell |
142,259
-38,913
| -21% | -$15.2M | 4.28% | 8 |
|
|
2023
Q1 | $67.5M | Buy |
181,172
+91,616
| +102% | +$34.1M | 6.4% | 4 |
|
|
2022
Q4 | $33.9M | Sell |
89,556
-741
| -0.8% | -$281K | 3.98% | 14 |
|
|
2022
Q3 | $31.9M | Buy |
90,297
+1,481
| +2% | +$523K | 4.25% | 9 |
|
|
2022
Q2 | $33.7M | Buy |
+88,816
| New | +$33.7M | 6.71% | 8 |
|
|
2022
Q1 | – | Sell |
-42,050
| Closed | -$14.7M | – | 26 |
|
|
2021
Q4 | $14.7M | Buy |
+42,050
| New | +$14.7M | 4.21% | 11 |
|